Related Experiment Videos
Vaccination against schistosomiasis in mice with killed schistosomula without adjuvant
Abstract:
Attempts to develop a killed vaccine against schistosomiasis have generally resulted in failure. There are two recent reports, but unfortunately, harsh adjuvants were used in conjunction with the antigenic materials. In our laboratory, a killed vaccine was developed by freezing (-196 degrees C) and thawing the schistosomula of S. mansoni. The use of such a preparation without adjuvant was effective in vaccinating mice. A worm reduction of 36.4-41.1% was achieved by one vaccinating injection, a 60.2% worm reduction by 3 injections, and a 63.7-66.0% reduction by 5 injections. The sequence of the development and the expression of the immune reactions were similar to those previously found in hosts immunized with highly X-irradiated schistosome organisms. Delayed hypersensitivity was demonstrated in histological sections of the skin in the challenged mice after one vaccination, showing that an adjuvant was not necessary to initiate the induction of cellular immunity.
Insights
Developing a killed vaccine against schistosomiasis (S. mansoni) is challenging. This study shows a novel freeze-thaw vaccine effectively immunizes mice without harsh adjuvants, reducing worm burden significantly.
Area of Science:
- Immunology
- Parasitology
- Vaccine Development
Background:
- Killed vaccines against schistosomiasis have historically failed, often due to the use of harsh adjuvants.
- Previous attempts highlight the difficulty in eliciting a protective immune response against Schistosoma mansoni using killed antigens.
Purpose of the Study:
- To develop an effective killed vaccine against schistosomiasis without the need for harsh adjuvants.
- To assess the efficacy of a novel vaccine preparation derived from freeze-thawed S. mansoni schistosomula in a murine model.
Main Methods:
- Schistosomula of S. mansoni were killed by repeated freezing (-196°C) and thawing cycles.
- Mice were vaccinated with the killed schistosomula preparation, with varying numbers of injections (1, 3, or 5).
- Vaccine efficacy was determined by measuring the reduction in worm burden post-challenge.
Main Results:
- A single vaccination injection resulted in a 36.4-41.1% reduction in worm burden.
- Multiple injections (3 or 5) led to significantly higher worm reductions of 60.2% and 63.7-66.0%, respectively.
- Cellular immunity, evidenced by delayed hypersensitivity, was induced after a single vaccination, indicating adjuvant-independent immune response initiation.
Conclusions:
- A killed vaccine against schistosomiasis (S. mansoni) can be effectively developed using a simple freeze-thaw method.
- This vaccine preparation is effective in conferring protection in mice without the requirement of harsh adjuvants.
- The induction of cellular immunity demonstrates the potential of this adjuvant-free vaccine strategy for schistosomiasis control.